Matches in Nanopublications for { ?s ?p "DDI between Rosiglitazone and Colesevelam - Bile Acid Sequestrants may decrease the absorption of Antidiabetic Agents (Thiazolidinedione). Separate the dosing of bile acid sequestrants and thiazolidinediones by at least 2 hours. Monitor for reduced effects of the antidiabetic agents. [drugbank_resource:DB00412_DB00930]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00412_DB00930 label "DDI between Rosiglitazone and Colesevelam - Bile Acid Sequestrants may decrease the absorption of Antidiabetic Agents (Thiazolidinedione). Separate the dosing of bile acid sequestrants and thiazolidinediones by at least 2 hours. Monitor for reduced effects of the antidiabetic agents. [drugbank_resource:DB00412_DB00930]" assertion.